Oakworth Capital, Inc. Bristol Myers Squibb CO Cont V Transaction History
Oakworth Capital, Inc.
- $1.45 Billion
- Q4 2024
A detailed history of Oakworth Capital, Inc. transactions in Bristol Myers Squibb CO Cont V stock. As of the latest transaction made, Oakworth Capital, Inc. holds 125 shares of CELGRT stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CELGRT
# of Institutions
21Shares Held
934KCall Options Held
0Put Options Held
0-
Murchinson Ltd. Toronto, A6400KShares$00.0% of portfolio
-
Transcend Capital Advisors, LLC118KShares$00.0% of portfolio
-
Four World Capital Management LLC New York, NY100KShares$00.0% of portfolio
-
Davenport & CO LLC84KShares$00.0% of portfolio
-
Maven Securities LTD St Helier, Y967.9KShares$00.0% of portfolio